Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study. Cardiovasc Diabetol. 2014 Mar 28;13:65.
Ref 1572592
NCBI GEO: archive for functional genomics data sets--update.
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.